Business Description
Neuland Laboratories Ltd
ISIN : INE794A01010
Compare
Compare
Traded in other countries / regions
524558.India IPO Date
1994-07-05Description
Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.26 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.2 | |||||
Interest Coverage | 28.78 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 12.4 | |||||
Beneish M-Score | -2.16 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.2 | |||||
3-Year EBITDA Growth Rate | 44.4 | |||||
3-Year EPS without NRI Growth Rate | 54.8 | |||||
3-Year FCF Growth Rate | 11.9 | |||||
3-Year Book Growth Rate | 17.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 13.38 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 88.2 | |||||
9-Day RSI | 81.62 | |||||
14-Day RSI | 73.59 | |||||
6-1 Month Momentum % | 14.57 | |||||
12-1 Month Momentum % | 113.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.15 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 153.52 | |||||
Days Sales Outstanding | 82.76 | |||||
Days Payable | 89.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.13 | |||||
Dividend Payout Ratio | 0.04 | |||||
3-Year Dividend Growth Rate | 71 | |||||
Forward Dividend Yield % | 0.18 | |||||
5-Year Yield-on-Cost % | 0.13 | |||||
Shareholder Yield % | 0.86 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.92 | |||||
Operating Margin % | 25.85 | |||||
Net Margin % | 19.25 | |||||
FCF Margin % | 7.54 | |||||
ROE % | 26.4 | |||||
ROA % | 17.73 | |||||
ROIC % | 21.48 | |||||
ROC (Joel Greenblatt) % | 47.22 | |||||
ROCE % | 32.73 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.02 | |||||
PE Ratio without NRI | 33.02 | |||||
Shiller PE Ratio | 110.3 | |||||
Price-to-Owner-Earnings | 42 | |||||
PEG Ratio | 0.7 | |||||
PS Ratio | 6.36 | |||||
PB Ratio | 7.72 | |||||
Price-to-Tangible-Book | 9.9 | |||||
Price-to-Free-Cash-Flow | 84.34 | |||||
Price-to-Operating-Cash-Flow | 37.95 | |||||
EV-to-EBIT | 23.8 | |||||
EV-to-Forward-EBIT | 14.46 | |||||
EV-to-EBITDA | 20.81 | |||||
EV-to-Forward-EBITDA | 10.15 | |||||
EV-to-Revenue | 6.34 | |||||
EV-to-Forward-Revenue | 1.64 | |||||
EV-to-FCF | 81.5 | |||||
Price-to-Projected-FCF | 6.56 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.32 | |||||
Price-to-Graham-Number | 3.81 | |||||
Price-to-Net-Current-Asset-Value | 26.7 | |||||
Earnings Yield (Greenblatt) % | 4.2 | |||||
FCF Yield % | 1.18 | |||||
Forward Rate of Return (Yacktman) % | 20.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neuland Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 15,585.805 | ||
EPS (TTM) (₹) | 233.89 | ||
Beta | 0.44 | ||
Volatility % | 60.76 | ||
14-Day RSI | 73.59 | ||
14-Day ATR (₹) | 335.961899 | ||
20-Day SMA (₹) | 6658.2025 | ||
12-1 Month Momentum % | 113.39 | ||
52-Week Range (₹) | 2799.8 - 8080 | ||
Shares Outstanding (Mil) | 12.83 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Neuland Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Neuland Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Neuland Laboratories Ltd Frequently Asked Questions
What is Neuland Laboratories Ltd(BOM:524558)'s stock price today?
The current price of BOM:524558 is ₹7725.00. The 52 week high of BOM:524558 is ₹8080.00 and 52 week low is ₹2799.80.
When is next earnings date of Neuland Laboratories Ltd(BOM:524558)?
The next earnings date of Neuland Laboratories Ltd(BOM:524558) is 2024-08-02 Est..
Does Neuland Laboratories Ltd(BOM:524558) pay dividends? If so, how much?
The Dividend Yield %  of Neuland Laboratories Ltd(BOM:524558) is 0.13% (As of Today), Highest Dividend Payout Ratio of Neuland Laboratories Ltd(BOM:524558) was 0.26. The lowest was 0.03. And the median was 0.05. The  Forward Dividend Yield % of Neuland Laboratories Ltd(BOM:524558) is 0.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |